11-17463609-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000352.6(ABCC8):c.413-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,569,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000352.6 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152090Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000940 AC: 17AN: 180818Hom.: 0 AF XY: 0.0000524 AC XY: 5AN XY: 95370
GnomAD4 exome AF: 0.0000649 AC: 92AN: 1417666Hom.: 0 Cov.: 32 AF XY: 0.0000642 AC XY: 45AN XY: 700734
GnomAD4 genome AF: 0.000519 AC: 79AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
Variant summary: ABCC8 c.413-5G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: One predict the variant abolishes a 3' acceptor site. Two predict the variant weakens a 3' acceptor site. Four predict the variant creates a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 9.4e-05 in 180818 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ABCC8 causing Familial Hyperinsulinism (9.4e-05 vs 0.0034), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.413-5G>A in individuals affected with Familial Hyperinsulinism and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 35613). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Type 2 diabetes mellitus;C0271714:Leucine-induced hypoglycemia;C1833104:Permanent neonatal diabetes mellitus;C1835887:Diabetes mellitus, transient neonatal, 2;C2931832:Hyperinsulinemic hypoglycemia, familial, 1 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.413-5G>A intronic alteration consists of a G to A substitution 5 nucleotides before exon 4 of the ABCC8 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Maturity onset diabetes mellitus in young Uncertain:1
Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs186946111) in MODY yet. -
Transitory neonatal diabetes mellitus Uncertain:1
Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs186946111) in neonatal diabetes yet. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at